1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsInstitutional Development Award (IDeA) Program is sponsored by National Institute of General Medical Sciences (NIGMS). The IDeA program is a congressionally mandated initiative that builds research capacity in states historically underrepresented in NIH funding.
Get alerted about grants like this
Get emailed when new opportunities from “National Institute of General Medical Sciences (NIGMS)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Institutional Development Award | National Institute of General Medical Sciences The Institutional Development Award (IDeA) is a congressionally mandated program that builds research capacity in states that historically have had low levels of NIH funding. It supports competitive basic, clinical, and translational research, faculty development, and infrastructure improvements.
The program aims to strengthen an institution’s ability to support biomedical research, enhance the competitiveness of investigators in securing research funding, and enable clinical and translational research that addresses the needs of medically underserved communities.
IDeA-eligible states include: Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Rhode Island, South Carolina, South Dakota, Vermont, West Virginia, Wyoming, and Puerto Rico IDeA-eligible states are shaded on the map below: The IDeA program has five main components: Centers of Biomedical Research Excellence (COBRE) The Centers of Biomedical Research Excellence (COBRE) program supports the establishment and development of innovative biomedical research centers through awards for three sequential five-year phases.
IDeA Networks of Biomedical Research Excellence (INBRE) The IDeA Networks of Biomedical Research Excellence (INBRE) program supports a statewide biomedical research development network in each IDeA-eligible state that partners research-intensive institutions with primarily undergraduate institutions.
IDeA Clinical and Translational Research Programs The IDeA Clinical and Translational Research Programs support clinical and translational research through programs that develop research infrastructure and human resources, enhance the ability of investigators and institutions to develop competitive clinical research programs, and strengthen collaborative research that addresses health conditions prevalent in IDeA states.
IDeA Co-funding supports R01 and R15 applications from investigators in IDeA-eligible states assigned to any NIH institute or Center (IC) that were not funded by an Institute or Center. NIH ICs select and submit eligible applications to NIGMS for consideration for IDeA Co-funding support.
IDeA Regional Entrepreneurship Development (I-RED) Program The IDeA Regional Entrepreneurship Development (I-RED) Program supports small business concerns in IDeA states to develop educational products that promote entrepreneurship in IDeA states' academic institutions.
Educational efforts utilizing these products are expected to build biomedical researchers' and students' entrepreneurial skills needed to translate scientific discoveries and innovative technologies into commercial products.
IDeA Interactive Portfolio Dashboard IDeA-Supported Research Cores IDeA-Eligible States [PDF] IDeA Support Attribution Instructions [PDF] IDeA Program Allowable Major Equipment for Alteration and Renovation Projects [PDF] This page last updated on
According to the current listing, eligibility includes: Institutions in IDeA-eligible states (including Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, P…. Confirm the full requirements in the official notice before applying.
Institutional Development Award (IDeA) Program is funded by National Institute of General Medical Sciences (NIGMS). Verify program details on the funder's official page before applying.
This opportunity targets applicants in 17 states, including New Hampshire, North Dakota, Mississippi, New Mexico, and Louisiana. Check the official notice for the full list.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Commercialization Readiness Pilot (CRP) Program (PAR-27-098) is sponsored by National Institutes of Health (NIH) / National Institute of General Medical Sciences (NIGMS). This program facilitates the transition of previously funded SBIR and STTR Phase 2 and Phase 2B projects to the commercialization stage by providing additional support for technical assistance and late-stage product development.
NIH Small Business Innovation Research (SBIR) Program (Parent SBIR [R43/R44] Clinical Trial Not Allowed) (PA-24-245) / (Parent SBIR [R43/R44] Clinical Trial Required) (PA-24-246) is sponsored by National Institutes of Health (NIH) / National Institute of General Medical Sciences (NIGMS). NIGMS participates in the NIH SBIR program, which supports small businesses engaging in research and development activities with strong potential for commercialization.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
Schmidt Sciences opened a 'Scaling AI Safety for a Multi-Agent World' program with awards up to $1 million and an August 8, 2026 deadline. Against a backdrop of federal research slowdowns, here is why private science philanthropy matters more than ever, how these funders differ from federal agencies, and how researchers should approach them.
Read articleCummings Foundation grew its annual local program from $30 million to $35 million for 2026 awards, but the dollar increase is the smaller story. Nearly every grant now flows as unrestricted general operating support — the funding nonprofits ask for most and receive least. For eligible Massachusetts organizations, the 2027 cycle opens July 15 with a September 16 letter-of-inquiry deadline. Here is who qualifies, why the shift to operating support changes the calculus, and how a small nonprofit should approach a program that hands out 150 grants a year, most of them chosen by community volunteers.
Read articleCummings Foundation raised its annual local grant program from $30M to $35M and is now awarding nearly all of it as unrestricted general operating support — including 25 grants paid over a full 10 years. Letters of inquiry for the 2027 cycle opened July 15 and close September 16, 2026. Here is who qualifies, how the multi-year structure works, and why the shift to unrestricted, decade-long funding matters more than the dollar increase.
Read article